Whether this is a result of the pancreas to counteract or compensate the impairing effects of the HFD at relatively early stage of T2D development, and the connection between this over-secretion of insulin and the upregulated HIF-1 signaling pathway particularly its downstream angiogenic functions, await further investigations. The gene discussed is HIF1A; the disease is type 2 diabetes mellitus.